News

Researchers said longitudinal studies are critical to refine and optimize the management of metabolic dysfunction–associated ...
Nicolas Ferreyros, managing director, Community Oncology Alliance, discusses key components of health equity and social determinants of health that need to be addressed in cancer care.
AZD0486 demonstrated encouraging safety and dose-dependent efficacy in heavily pretreated adolescent and adult patients with relapsed/refractory B-cell acute lymphoblastic leukemia (ALL), according to ...
This new study identifies key contributors to mental health decline in individuals with atopic dermatitis, highlighting the ...
Maridebart cafraglutide showed promising results in weight loss, offering a monthly treatment option for obesity with ...
While artificial intelligence (AI) holds promise to improve the diagnosis of melanoma, researchers of a new review outlined ...
Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the ...
The recent increase in prolonged emergency department (ED) stays and boarding times for older adults reveals systemic challenges in US hospital care.
Jody Agena, PharmD, MBA, director of pharmacy operations, Virginia Cancer Specialists, discusses the various responsibilities of the pharmacist within community oncology settings.
High infection rates among younger adults suggest they either delay routine dental care and only seek treatment when ...
The FDA has removed Risk Evaluation and Mitigation Strategies (REMS) for approved chimeric antigen receptor (CAR) T-cell therapies for hematologic malignancies, aiming to ease provider burden and ...
Rachel Rohaidy, MD, of Miami Neuroscience Institute and Baptist Health, discusses how the evolving treatment landscape is ...